For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Encompass Health Corp (NYSE: EHC) closed at $119.23 in the last session, down -0.89% from day before closing price of $120.30. In other words, the price has decreased by -$0.89 from its previous closing price. On the day, 0.52 million shares were traded.
Ratios:
We take a closer look at EHC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 71.79 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.10. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 1.25 whereas as Long-Term Debt/Eq ratio is at 1.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, KeyBanc Capital Markets on October 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $115.
On March 06, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $95.Barclays initiated its Overweight rating on March 06, 2024, with a $95 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 20 ’25 when Tarr Mark J sold 118,384 shares for $121.53 per share. The transaction valued at 14,387,152 led to the insider holds 527,070 shares of the business.
Mark Tarr bought 118,384 shares of EHC for $14,383,656 on May 20 ’25. On May 06 ’25, another insider, Charbonneau Elissa Joy, who serves as the Chief Medical Officer of the company, sold 4,279 shares for $116.61 each. As a result, the insider received 498,974 and left with 11,958 shares of the company.
Valuation Measures:
As of this moment, Encompass’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.61, and their Forward P/E ratio for the next fiscal year is 21.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.18 while its Price-to-Book (P/B) ratio in mrq is 5.57.
Stock Price History:
Over the past 52 weeks, EHC has reached a high of $123.13, while it has fallen to a 52-week low of $82.74. The 50-Day Moving Average of the stock is 6.17%, while the 200-Day Moving Average is calculated to be 18.26%.
Shares Statistics:
A total of 100.90M shares are outstanding, with a floating share count of 99.18M. Insiders hold about 1.61% of the company’s shares, while institutions hold 96.55% stake in the company.
